Where science becomes communication
A selection of medical and scientific writing projects showing how complex evidence becomes clear, accurate, audience-focused communication.
Explore my work across scientific publications, clinical and medical communications, conference materials, scientific storytelling, data visualization, medical education, and marketing content each project grounded in the evidence and built for its intended audience.
Patient-Centric Informed Consent Design
(Mock ICF + Snapshot Video)
This features a fully regulated mock ICF and a 3-minute snapshot that distills essential study information for patients.
Patient-Centric Surgical Communication Design
(IONM Infographic + 5-Minute Walkthrough Video)
This project demonstrates a complex surgical and neuromonitoring procedure in a clear, patient-friendly narrative that improves patient understanding, confidence, and engagement in surgical care.
GLP-1 Market Forecast: Eli Lilly vs Novo Nordisk
MOA of dual-targeted therapy in BRAF-mutant mCRC
Key Insights from BREAKWATER Cohort 3
Bayesian Methods in Clinical Trials: FDA Guidance and the Future of Drug Development
frontMIND Phase III clinical trial results
Top 5 FDA-Approved Therapies of 2025
Tracing Oral Wegovy’s Path to Approval
Orforglipron: ATTAIN-MAINTAIN Phase III Snapshot
Key Insights from TRIUMPH-4
Key Insights from NCCN 2026 - From Chemotherapy to ADCs
A quantum leap in obesity treatment: Phase 3 TRIUMPH-4 data
Breaking Waves in mCRC: Encorafenib combo ushers in a new era for BRAF-Mutated cancers
Reimagining FDA guidance on tissue biopsies in clinical trials: a critical analysis
How minimal residual disease (MRD) testing with ctDNA analysis is revolutionizing the future of oncology treatment
A new era in medical writing: AI as the catalyst for change
Publications
Selected Publications
Fetal-like reversion in the regenerating intestine is regulated by mesenchymal asporin. Cell Stem Cell, 2025. Impact Factor: 25.2
Park B, Kumar A, et al. Leveraging morphological profiling for mechanistic elucidation of metal-based anticancer compounds. JACS Au. 2026. Impact Fcator: 8.5
yylncT defines a class of divergently transcribed lncRNAs and safeguards T-mediated mesodermal commitment of human PSCs. Cell Stem Cell, 2019. Impact Factor: 25.2
Haploinsufficiency of miR-143 and miR-145 reveals targetable dependencies in resistant del(5q) myelodysplastic neoplasm. Leukemia, 2025. Impact Factor: 13.4
Detection of RNA–DNA binding sites in long noncoding RNAs. Nucleic Acids Research, 2019. Impact Factor: 16.8
Pan-cancer analysis of S-phase–enriched lncRNAs identifies oncogenic drivers and biomarkers. Nature Communications, 2018. Impact Factor: 17.2
Long non-coding RNAs: emerging functional players in the pathobiology and progression of myeloid leukemia. Frontiers in RNA Research, 2024. Impact Factor: 6.3
Sestrin2 facilitates mitophagy by promoting Parkin translocation through ULK1-mediated Beclin1 phosphorylation. 2018, Scientific Reports. Impact Factor: 5.5
Sestrin2 facilitates glutamine-dependent transcription of PGC-1α and survival of liver cancer cells under glucose limitation. FEBS, 2018, Impact Factor: 5.62
RBX1-mediated ubiquitination of SESN2 promotes cell death upon prolonged mitochondrial damage in SH-SY5Y neuroblastoma cells. Molecular and Cellular Biochemistry, 2018. Impact Factor: 4.7
Sestrins: Darkhorse in the regulation of mitochondrial health and metabolism. Mol Bio Rep., 2023, Impact Factor: 3.2
Association of preoperative serum adipokines, insulin, and sex steroid hormones with breast cancer risk in Indian women. Indian Journal of Cancer, 2024. Impact Factor: 1.3